Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04828330 · ClinicalTrials.gov registry record
Flares of Low Back Pain With Activity Research Study
A clinical trial, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- 416
- Enrollment target
NCT04828330: Completed study, sponsored by VA Office of Research and Development.
NCT04828330 is a clinical trial that has completed, run by VA Office of Research and Development. The registered enrollment target is 416 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04828330 has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- 416 participants
- Enrollment target
Study Summary
Low back pain (LBP) is the most common cause of disability worldwide. Although general activity is encouraged in the treatment of LBP, there is limited empirical information available on the specific types of activities that are beneficial or harmful for patients seen in primary care for LBP. This study will identify those physical activities with short-term (transient) effects on LBP exacerbations (or "flares" of LBP), as well as identifying the long-term (cumulative) effects of such activities on functional recovery.
Primary Outcome
At each study assessment, participants are presented with the flare definition used in this study, which was derived from a previously validated flare definition by Costa et al (2000). The definition is: "A 'flare' of low back pain is a worsening of your low back pain that lasts from hours to weeks". Participants are then asked to self-report whether a flare of low back pain is currently ongoing, by responding to the question "According to the definition above, are you currently experiencing a
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 416 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2024-10-24 |
What the finished NCT04828330 record still lists
NCT04828330 is an observational study that tracks outcomes without assigning an intervention. The registered 416 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04828330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04828330 about?
NCT04828330 is a clinical study titled "Flares of Low Back Pain With Activity Research Study". Low back pain (LBP) is the most common cause of disability worldwide. Although general activity is encouraged in the treatment of LBP, there is limited empirical information available on the specific types of activities that are beneficial or harmful for patients seen in primary care for LBP. This s...
What is the current status of trial NCT04828330?
This trial is currently completed. The enrollment target is 416 participants. The study started on 2021-03-25. Estimated completion is 2024-10-24.
Who is sponsoring clinical trial NCT04828330?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- NCT06075745 · 416 participants · Phase 2
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI